Allergy Drugs Market Research Report by Type (Drug Allergy, Food Allergy, and Inhaled Allergy), by Treatment (Anti-allergy Drugs and Immunotherapy), by Distribution Channels - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Allergy Drugs Market is expected to grow from USD 23,486.31 Million in 2020 to USD 33,642.94 Million by the end of 2025.
2. The Global Allergy Drugs Market is expected to grow from EUR 20,593.24 Million in 2020 to EUR 29,498.76 Million by the end of 2025.
3. The Global Allergy Drugs Market is expected to grow from GBP 18,307.43 Million in 2020 to GBP 26,224.46 Million by the end of 2025.
4. The Global Allergy Drugs Market is expected to grow from JPY 2,506,584.42 Million in 2020 to JPY 3,590,554.21 Million by the end of 2025.
5. The Global Allergy Drugs Market is expected to grow from AUD 34,105.24 Million in 2020 to AUD 48,854.02 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Allergy Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the Allergy Drugs Market studied across Drug Allergy, Food Allergy, and Inhaled Allergy.
Based on Treatment, the Allergy Drugs Market studied across Anti-allergy Drugs and Immunotherapy. The Anti-allergy Drugs further studied across Antihistamines, Corticosteroids, and Leukotriene Inhibitors. The Immunotherapy further studied across Subcutaneous Immunotherapy (SCIT) Sublingual Immunotherapy (SLIT).
Based on Distribution Channels, the Allergy Drugs Market studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies & Drug Stores.
Based on Geography, the Allergy Drugs Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Allergy Drugs Market including AbbVie Inc., Aimmune Therapeutics, Inc, ALK-Abell? A/S, Allergy Therapeutics, Amneal Pharmaceuticals PLC, Astra Biotech GmbH, AstraZeneca PLC, Aurobindo Pharma, Bayer AG, Cadila Healthcare Limited, Chongqing Huapont Pharmaceutical Co., Ltd, Cipla Inc, Dr. Reddy’s Laboratories Ltd, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, HAL Allergy B.V., Hikma Pharmaceuticals PLC, Johnson & Johnson Services, Inc, LETI Pharma GmBH, Lupin Limited, Magna Pharmaceuticals, Inc., Merck & Co., Inc, Mylan N.V, Novartis AG, Sanofi SA, Stallergenes Greer Ltd, Sun Pharmaceutical Industries Ltd, and Teva Pharmaceutical Industries Ltd.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Allergy Drugs Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Allergy Drugs Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Allergy Drugs Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Allergy Drugs Market?
4. What is the competitive strategic window for opportunities in the Global Allergy Drugs Market?
5. What are the technology trends and regulatory frameworks in the Global Allergy Drugs Market?
6. What are the modes and strategic moves considered suitable for entering the Global Allergy Drugs Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Allergy Drugs Market is expected to grow from USD 23,486.31 Million in 2020 to USD 33,642.94 Million by the end of 2025.
2. The Global Allergy Drugs Market is expected to grow from EUR 20,593.24 Million in 2020 to EUR 29,498.76 Million by the end of 2025.
3. The Global Allergy Drugs Market is expected to grow from GBP 18,307.43 Million in 2020 to GBP 26,224.46 Million by the end of 2025.
4. The Global Allergy Drugs Market is expected to grow from JPY 2,506,584.42 Million in 2020 to JPY 3,590,554.21 Million by the end of 2025.
5. The Global Allergy Drugs Market is expected to grow from AUD 34,105.24 Million in 2020 to AUD 48,854.02 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Allergy Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the Allergy Drugs Market studied across Drug Allergy, Food Allergy, and Inhaled Allergy.
Based on Treatment, the Allergy Drugs Market studied across Anti-allergy Drugs and Immunotherapy. The Anti-allergy Drugs further studied across Antihistamines, Corticosteroids, and Leukotriene Inhibitors. The Immunotherapy further studied across Subcutaneous Immunotherapy (SCIT) Sublingual Immunotherapy (SLIT).
Based on Distribution Channels, the Allergy Drugs Market studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies & Drug Stores.
Based on Geography, the Allergy Drugs Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Allergy Drugs Market including AbbVie Inc., Aimmune Therapeutics, Inc, ALK-Abell? A/S, Allergy Therapeutics, Amneal Pharmaceuticals PLC, Astra Biotech GmbH, AstraZeneca PLC, Aurobindo Pharma, Bayer AG, Cadila Healthcare Limited, Chongqing Huapont Pharmaceutical Co., Ltd, Cipla Inc, Dr. Reddy’s Laboratories Ltd, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, HAL Allergy B.V., Hikma Pharmaceuticals PLC, Johnson & Johnson Services, Inc, LETI Pharma GmBH, Lupin Limited, Magna Pharmaceuticals, Inc., Merck & Co., Inc, Mylan N.V, Novartis AG, Sanofi SA, Stallergenes Greer Ltd, Sun Pharmaceutical Industries Ltd, and Teva Pharmaceutical Industries Ltd.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Allergy Drugs Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Allergy Drugs Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Allergy Drugs Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Allergy Drugs Market?
4. What is the competitive strategic window for opportunities in the Global Allergy Drugs Market?
5. What are the technology trends and regulatory frameworks in the Global Allergy Drugs Market?
6. What are the modes and strategic moves considered suitable for entering the Global Allergy Drugs Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Type Outlook
3.4. Treatment Outlook
3.5. Distribution Channels Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of allergy globally
5.1.1.2. Increasing development of allergy-specific drugs
5.1.1.3. Changing lifestyle with increasing tobacco consumption
5.1.2. Restraints
5.1.2.1. Concerns over patent expiration and extensive competition from generic drugs
5.1.3. Opportunities
5.1.3.1. Introduction of immunotherapy and development of increasing ways of administration
5.1.3.2. Rising consumer awareness on food allergies
5.1.4. Challenges
5.1.4.1. Availability of alternative drugs for allergy
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL ALLERGY DRUGS MARKET, BY TYPE
6.1. Introduction
6.2. Drug Allergy
6.3. Food Allergy
6.4. Inhaled Allergy
7. GLOBAL ALLERGY DRUGS MARKET, BY TREATMENT
7.1. Introduction
7.2. Anti-allergy Drugs
7.2.1. Antihistamines
7.2.2. Corticosteroids
7.2.3. Leukotriene Inhibitors
7.3. Immunotherapy
7.3.1. Subcutaneous Immunotherapy (SCIT) Sublingual Immunotherapy (SLIT)
8. GLOBAL ALLERGY DRUGS MARKET, BY DISTRIBUTION CHANNELS
8.1. Introduction
8.2. Hospital Pharmacies
8.3. Online Pharmacies
8.4. Retail Pharmacies & Drug Stores
9. AMERICAS ALLERGY DRUGS MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC ALLERGY DRUGS MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. AbbVie Inc.
13.2. Aimmune Therapeutics, Inc
13.3. ALK-Abell? A/S
13.4. Allergy Therapeutics
13.5. Amneal Pharmaceuticals PLC
13.6. Astra Biotech GmbH
13.7. AstraZeneca PLC
13.8. Aurobindo Pharma
13.9. Bayer AG
13.10. Cadila Healthcare Limited
13.11. Chongqing Huapont Pharmaceutical Co., Ltd
13.12. Cipla Inc
13.13. Dr. Reddy’s Laboratories Ltd
13.14. F. Hoffmann-La Roche AG
13.15. GlaxoSmithKline PLC
13.16. HAL Allergy B.V.
13.17. Hikma Pharmaceuticals PLC
13.18. Johnson & Johnson Services, Inc
13.19. LETI Pharma GmBH
13.20. Lupin Limited
13.21. Magna Pharmaceuticals, Inc.
13.22. Merck & Co., Inc
13.23. Mylan N.V
13.24. Novartis AG
13.25. Sanofi SA
13.26. Stallergenes Greer Ltd
13.27. Sun Pharmaceutical Industries Ltd
13.28. Teva Pharmaceutical Industries Ltd
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Type Outlook
3.4. Treatment Outlook
3.5. Distribution Channels Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of allergy globally
5.1.1.2. Increasing development of allergy-specific drugs
5.1.1.3. Changing lifestyle with increasing tobacco consumption
5.1.2. Restraints
5.1.2.1. Concerns over patent expiration and extensive competition from generic drugs
5.1.3. Opportunities
5.1.3.1. Introduction of immunotherapy and development of increasing ways of administration
5.1.3.2. Rising consumer awareness on food allergies
5.1.4. Challenges
5.1.4.1. Availability of alternative drugs for allergy
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL ALLERGY DRUGS MARKET, BY TYPE
6.1. Introduction
6.2. Drug Allergy
6.3. Food Allergy
6.4. Inhaled Allergy
7. GLOBAL ALLERGY DRUGS MARKET, BY TREATMENT
7.1. Introduction
7.2. Anti-allergy Drugs
7.2.1. Antihistamines
7.2.2. Corticosteroids
7.2.3. Leukotriene Inhibitors
7.3. Immunotherapy
7.3.1. Subcutaneous Immunotherapy (SCIT) Sublingual Immunotherapy (SLIT)
8. GLOBAL ALLERGY DRUGS MARKET, BY DISTRIBUTION CHANNELS
8.1. Introduction
8.2. Hospital Pharmacies
8.3. Online Pharmacies
8.4. Retail Pharmacies & Drug Stores
9. AMERICAS ALLERGY DRUGS MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC ALLERGY DRUGS MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. AbbVie Inc.
13.2. Aimmune Therapeutics, Inc
13.3. ALK-Abell? A/S
13.4. Allergy Therapeutics
13.5. Amneal Pharmaceuticals PLC
13.6. Astra Biotech GmbH
13.7. AstraZeneca PLC
13.8. Aurobindo Pharma
13.9. Bayer AG
13.10. Cadila Healthcare Limited
13.11. Chongqing Huapont Pharmaceutical Co., Ltd
13.12. Cipla Inc
13.13. Dr. Reddy’s Laboratories Ltd
13.14. F. Hoffmann-La Roche AG
13.15. GlaxoSmithKline PLC
13.16. HAL Allergy B.V.
13.17. Hikma Pharmaceuticals PLC
13.18. Johnson & Johnson Services, Inc
13.19. LETI Pharma GmBH
13.20. Lupin Limited
13.21. Magna Pharmaceuticals, Inc.
13.22. Merck & Co., Inc
13.23. Mylan N.V
13.24. Novartis AG
13.25. Sanofi SA
13.26. Stallergenes Greer Ltd
13.27. Sun Pharmaceutical Industries Ltd
13.28. Teva Pharmaceutical Industries Ltd
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL ALLERGY DRUGS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DRUG ALLERGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL ALLERGY DRUGS MARKET SIZE, BY FOOD ALLERGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL ALLERGY DRUGS MARKET SIZE, BY INHALED ALLERGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ANTIHISTAMINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL ALLERGY DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL ALLERGY DRUGS MARKET SIZE, BY LEUKOTRIENE INHIBITORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL ALLERGY DRUGS MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY (SCIT) SUBLINGUAL IMMUNOTHERAPY (SLIT), BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL ALLERGY DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL ALLERGY DRUGS MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. AMERICAS ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. AMERICAS ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. AMERICAS ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. AMERICAS ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. BRAZIL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. BRAZIL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. BRAZIL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. CANADA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. CANADA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. CANADA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. MEXICO ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. MEXICO ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. MEXICO ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. AUSTRALIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. AUSTRALIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. AUSTRALIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. CHINA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. CHINA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. CHINA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. INDIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. INDIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. INDIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. INDONESIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. INDONESIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. INDONESIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. JAPAN ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. JAPAN ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. JAPAN ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. THAILAND ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. THAILAND ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. THAILAND ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. FRANCE ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. FRANCE ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. FRANCE ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. GERMANY ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. GERMANY ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. GERMANY ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. ITALY ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. ITALY ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. ITALY ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. QATAR ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. QATAR ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. QATAR ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. RUSSIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. RUSSIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. RUSSIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. SPAIN ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. SPAIN ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. SPAIN ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. GLOBAL ALLERGY DRUGS MARKET: SCORES
TABLE 107. GLOBAL ALLERGY DRUGS MARKET: BUSINESS STRATEGY
TABLE 108. GLOBAL ALLERGY DRUGS MARKET: PRODUCT SATISFACTION
TABLE 109. GLOBAL ALLERGY DRUGS MARKET: RANKING
TABLE 110. GLOBAL ALLERGY DRUGS MARKET: MERGER & ACQUISITION
TABLE 111. GLOBAL ALLERGY DRUGS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 112. GLOBAL ALLERGY DRUGS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 113. GLOBAL ALLERGY DRUGS MARKET: INVESTMENT & FUNDING
TABLE 114. GLOBAL ALLERGY DRUGS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 115. GLOBAL ALLERGY DRUGS MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL ALLERGY DRUGS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DRUG ALLERGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL ALLERGY DRUGS MARKET SIZE, BY FOOD ALLERGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL ALLERGY DRUGS MARKET SIZE, BY INHALED ALLERGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ANTIHISTAMINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL ALLERGY DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL ALLERGY DRUGS MARKET SIZE, BY LEUKOTRIENE INHIBITORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL ALLERGY DRUGS MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY (SCIT) SUBLINGUAL IMMUNOTHERAPY (SLIT), BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL ALLERGY DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL ALLERGY DRUGS MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. AMERICAS ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. AMERICAS ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. AMERICAS ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. AMERICAS ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. BRAZIL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. BRAZIL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. BRAZIL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. CANADA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. CANADA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. CANADA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. MEXICO ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. MEXICO ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. MEXICO ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. AUSTRALIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. AUSTRALIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. AUSTRALIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. CHINA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. CHINA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. CHINA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. INDIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. INDIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. INDIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. INDONESIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. INDONESIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. INDONESIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. JAPAN ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. JAPAN ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. JAPAN ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. THAILAND ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. THAILAND ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. THAILAND ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. FRANCE ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. FRANCE ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. FRANCE ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. GERMANY ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. GERMANY ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. GERMANY ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. ITALY ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. ITALY ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. ITALY ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. QATAR ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. QATAR ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. QATAR ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. RUSSIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. RUSSIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. RUSSIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. SPAIN ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. SPAIN ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. SPAIN ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. GLOBAL ALLERGY DRUGS MARKET: SCORES
TABLE 107. GLOBAL ALLERGY DRUGS MARKET: BUSINESS STRATEGY
TABLE 108. GLOBAL ALLERGY DRUGS MARKET: PRODUCT SATISFACTION
TABLE 109. GLOBAL ALLERGY DRUGS MARKET: RANKING
TABLE 110. GLOBAL ALLERGY DRUGS MARKET: MERGER & ACQUISITION
TABLE 111. GLOBAL ALLERGY DRUGS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 112. GLOBAL ALLERGY DRUGS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 113. GLOBAL ALLERGY DRUGS MARKET: INVESTMENT & FUNDING
TABLE 114. GLOBAL ALLERGY DRUGS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 115. GLOBAL ALLERGY DRUGS MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL ALLERGY DRUGS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ALLERGY DRUGS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL ALLERGY DRUGS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 5. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2020 (USD MILLION)
FIGURE 6. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2020 (USD MILLION)
FIGURE 7. GLOBAL ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL ALLERGY DRUGS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL ALLERGY DRUGS MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL ALLERGY DRUGS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 15. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2025
FIGURE 17. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DRUG ALLERGY, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL ALLERGY DRUGS MARKET SIZE, BY FOOD ALLERGY, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL ALLERGY DRUGS MARKET SIZE, BY INHALED ALLERGY, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2020 VS 2025 (%)
FIGURE 21. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2020 VS 2025 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2025
FIGURE 23. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ANTIHISTAMINES, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL ALLERGY DRUGS MARKET SIZE, BY CORTICOSTEROIDS, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL ALLERGY DRUGS MARKET SIZE, BY LEUKOTRIENE INHIBITORS, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL ALLERGY DRUGS MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY (SCIT) SUBLINGUAL IMMUNOTHERAPY (SLIT), 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2020 VS 2025 (%)
FIGURE 30. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2020 VS 2025 (USD MILLION)
FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2025
FIGURE 32. GLOBAL ALLERGY DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2020 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL ALLERGY DRUGS MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, 2020 VS 2025 (USD MILLION)
FIGURE 35. AMERICAS ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 36. AMERICAS ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 38. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. BRAZIL ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. CANADA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 41. MEXICO ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 44. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 45. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 46. AUSTRALIA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. CHINA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. INDIA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. INDONESIA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. JAPAN ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. THAILAND ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 56. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 57. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 58. FRANCE ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. GERMANY ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. ITALY ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. QATAR ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. RUSSIA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. SPAIN ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. GLOBAL ALLERGY DRUGS MARKET: 360IRESEARCH™ FPNV POSITIONING MATRIX
FIGURE 70. GLOBAL ALLERGY DRUGS MARKET: 360IRESEARCH™ MARKET SHARE ANALYSIS
FIGURE 71. GLOBAL ALLERGY DRUGS MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 72. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ALLERGY DRUGS MARKET, BY TYPE
FIGURE 1. GLOBAL ALLERGY DRUGS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ALLERGY DRUGS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL ALLERGY DRUGS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 5. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2020 (USD MILLION)
FIGURE 6. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2020 (USD MILLION)
FIGURE 7. GLOBAL ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL ALLERGY DRUGS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL ALLERGY DRUGS MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL ALLERGY DRUGS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 15. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2025
FIGURE 17. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DRUG ALLERGY, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL ALLERGY DRUGS MARKET SIZE, BY FOOD ALLERGY, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL ALLERGY DRUGS MARKET SIZE, BY INHALED ALLERGY, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2020 VS 2025 (%)
FIGURE 21. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2020 VS 2025 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2025
FIGURE 23. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ANTIHISTAMINES, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL ALLERGY DRUGS MARKET SIZE, BY CORTICOSTEROIDS, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL ALLERGY DRUGS MARKET SIZE, BY LEUKOTRIENE INHIBITORS, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL ALLERGY DRUGS MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY (SCIT) SUBLINGUAL IMMUNOTHERAPY (SLIT), 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2020 VS 2025 (%)
FIGURE 30. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2020 VS 2025 (USD MILLION)
FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2025
FIGURE 32. GLOBAL ALLERGY DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2020 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL ALLERGY DRUGS MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, 2020 VS 2025 (USD MILLION)
FIGURE 35. AMERICAS ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 36. AMERICAS ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 38. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. BRAZIL ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. CANADA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 41. MEXICO ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 44. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 45. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 46. AUSTRALIA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. CHINA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. INDIA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. INDONESIA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. JAPAN ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. THAILAND ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 56. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 57. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 58. FRANCE ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. GERMANY ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. ITALY ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. QATAR ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. RUSSIA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. SPAIN ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. GLOBAL ALLERGY DRUGS MARKET: 360IRESEARCH™ FPNV POSITIONING MATRIX
FIGURE 70. GLOBAL ALLERGY DRUGS MARKET: 360IRESEARCH™ MARKET SHARE ANALYSIS
FIGURE 71. GLOBAL ALLERGY DRUGS MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 72. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ALLERGY DRUGS MARKET, BY TYPE
